Xeroderma of eyelid
ICD-10 H01.14 is a used to indicate a diagnosis of xeroderma of eyelid.
Xeroderma of the eyelid, also known as dry skin of the eyelid, is characterized by a deficiency of moisture in the skin surrounding the eyes, leading to symptoms such as itching, redness, and scaling. The eyelids are composed of delicate skin that is prone to environmental factors, including sun exposure, wind, and low humidity, which can exacerbate dryness. The condition may be associated with other dermatological disorders, such as eczema or psoriasis, and can also result from systemic conditions like hypothyroidism or Sjögren's syndrome. Diagnosis typically involves a thorough clinical examination and patient history to identify underlying causes. Treatment may include the use of emollients, topical corticosteroids, or other moisturizers to alleviate symptoms and restore skin integrity. In chronic cases, referral to a dermatologist may be warranted for further evaluation and management. Understanding the anatomy of the eyelid, including the skin layers, muscle structures, and associated glands, is crucial for effective treatment and management of xeroderma.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
H01.14 specifically covers xeroderma of the eyelid, which may be associated with conditions such as atopic dermatitis, contact dermatitis, or systemic diseases that cause dry skin. It is essential to differentiate it from other eyelid disorders like blepharitis or dermatitis.
H01.14 should be used when the primary diagnosis is xeroderma of the eyelid without other specified causes. If the xeroderma is secondary to another condition, a different code may be more appropriate.
Documentation should include a detailed patient history, clinical examination findings, any associated symptoms, and treatment plans. Evidence of previous treatments and their outcomes can also support the use of this code.
